Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Keisuke, Shiokawa"'
Autor:
Manabu Nakazawa, Yukinori Imai, Yoichi Saito, Masamitsu Nakao, Yohei Fujii, Hayato Uemura, Satoshi Mochida, Yoshihito Uchida, Mie Inao, Tomoaki Tomiya, Kayoko Sugawara, Keisuke Shiokawa, Kayoko Naiki, Daisuke Motoya, Shinpei Yamaba, Nobuaki Nakayama, Satsuki Ando, Jun-ichi Kouyama, Hiroshi Uchiya, Akira Fuchigami
Publikováno v:
Hepatology Research. 48:233-243
Aim To improve the therapeutic efficacy of sofosbuvir/ledipasvir (SOF/LDV) for the retreatment of patients after daclatasvir/asunaprevir (DCV/ASV), a customized therapy with or without lead-in interferon (IFN)-β injections was formulated according t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f814bced0f65a2b3e0b88c6a2c83afa
https://doi.org/10.1111/hepr.12980
https://doi.org/10.1111/hepr.12980
Autor:
Hayato, Uemura, Yoshihito, Uchida, Jun-Ichi, Kouyama, Kayoko, Naiki, Shinpei, Yamaba, Akira, Fuchigami, Yoichi, Saito, Keisuke, Shiokawa, Yohei, Fujii, Hiroshi, Uchiya, Manabu, Nakazawa, Satsuki, Ando, Masamitsu, Nakao, Daisuke, Motoya, Kayoko, Sugawara, Mie, Inao, Yukinori, Imai, Nobuaki, Nakayama, Tomoaki, Tomiya, Satoshi, Mochida
Publikováno v:
Hepatology research : the official journal of the Japan Society of Hepatology. 48(4)
To improve the therapeutic efficacy of sofosbuvir/ledipasvir (SOF/LDV) for the retreatment of patients after daclatasvir/asunaprevir (DCV/ASV), a customized therapy with or without lead-in interferon (IFN)-β injections was formulated according to th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c944f47a26f35758e4e12d6cf09a2757
https://pubmed.ncbi.nlm.nih.gov/28884930
https://pubmed.ncbi.nlm.nih.gov/28884930